1. Home
  2. HLX vs VIR Comparison

HLX vs VIR Comparison

Compare HLX & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helix Energy Solutions Group Inc.

HLX

Helix Energy Solutions Group Inc.

HOLD

Current Price

$6.26

Market Cap

942.8M

Sector

Energy

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$6.02

Market Cap

825.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLX
VIR
Founded
1979
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
942.8M
825.0M
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
HLX
VIR
Price
$6.26
$6.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
11
Target Price
$10.50
$25.73
AVG Volume (30 Days)
1.7M
2.0M
Earning Date
10-22-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
497.36
N/A
EPS
0.28
N/A
Revenue
$1,312,445,000.00
$16,860,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.96
$46.25
P/E Ratio
$22.16
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.52
$4.16
52 Week High
$9.75
$14.45

Technical Indicators

Market Signals
Indicator
HLX
VIR
Relative Strength Index (RSI) 39.49 48.14
Support Level $6.11 $5.73
Resistance Level $6.60 $6.16
Average True Range (ATR) 0.23 0.36
MACD -0.10 -0.08
Stochastic Oscillator 9.61 22.93

Price Performance

Historical Comparison
HLX
VIR

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. the Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: